Topical diltiazem cream ph. 3 trial data coming soon... since a lot of studies have already been done showing the drugs effectiveness and safety, there is no reason to believe it will not pass the trial.
The drug which failed ph. 3 trials and resulted in the lawsuits was and experimental drug and therefore much riskier and unpredictable. Diltiazem should have predictable results and eventually get approved.